SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001694665-23-000118
Filing Date
2023-07-12
Accepted
2023-07-12 16:06:45
Documents
2
Period of Report
2023-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1689192394.html 3  
1 FORM 3 wk-form3_1689192394.xml 3 1658
2 EX-24 evelo-section16poaxareynol.htm EX-24 8426
  Complete submission text file 0001694665-23-000118.txt   11466
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139
Business Address
Reynolds Alexander C (Reporting) CIK: 0001984687 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38473 | Film No.: 231084285